Notes
Comparative Effectiveness Public Advisory Council
References
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Publishes Guidance on Improving the Development and Use of Real World Evidence for Drug Coverage and Formulary Decisions. Internet Document : 10 Apr 2018. Available from: URL: https://icer-review.org/announcements/institute-for-clinical-and-economic-review-publishes-guidance-on-improving-the-development-and-use-of-real-world-evidence-for-drug-coverage-and-formulary-decisions/.
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Releases Draft Evidence Report on CGRP Inhibitors for Migraine Prevention Internet Document : 11 Apr 2018. Available from: URL: https://icer-review.org/announcements/draft-migraine-report/.
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review to Assess Medication-Assisted Therapy for Treatment of Opioid Use Disorder. Internet Document : 5 Apr 2018. Available from: URL: https://icer-review.org/announcements/mat/.
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Posts Draft Scoping Document on Therapies for Prevention of Hereditary Angioedema Attacks. Internet Document : 12 Apr 2018. Available from: URL: https://icer-review.org/announcements/hae-draft-scope/.
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review's Final Report on Emicizumab Shows New Treatment Improves Health While Lowering Costs for Certain People with Hemophilia A. Internet Document : 16 Apr 2018. Available from: URL: https://icer-review.org/announcements/hemophilia-final-report/.
Rights and permissions
About this article
Cite this article
Recent news from Institute for Clinical and Economic Review. PharmacoEcon Outcomes News 801, 3 (2018). https://doi.org/10.1007/s40274-018-4858-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4858-6